InvestorsHub Logo

Dieselpro

04/16/21 3:39 PM

#159311 RE: justdafactss #159310

What does FDA trials and approvals in the U.S. have to do with the Philippines? If this is all you can provide for a link that says CytoDyn cannot sell Leronlimab under CSP then you've provided proof there is no link.

Pctwst

04/16/21 4:01 PM

#159320 RE: justdafactss #159310

You are aware of what "to date" means? in this case it simply means the end date of the time period covered in the 10Q.

10Q confirmed NO REVENUES to date--



None of that matters. It is a pre-rev bio-tech in trials. Now broadening it's horizons in other countries. The Philippines will turn into revenue very shortly.

It is my opinion the "NO REVENUES to date" will be changing very shortly. Once the sales begin in the Philippines based on Estrada and the other 25 CSP cases, other countries will also be jumping on board if not already. The bonus is: The FDA and hopefully Fauci may have to answer some serious questions if a US made drug is saving people in other countries but not here in the US.

Anyway. in my opinion, things they are a changing and things are looking up.

Bourbon_on_my_cornflakes

04/16/21 5:45 PM

#159366 RE: justdafactss #159310

Philippines came later: 10Q confirmed NO REVENUES to date--

For the three and nine months ended February 28, 2021 and February 29, 2020,

Doses to Philippines sent AFTER FEbruary 29

That's the fact, Jack.

Bourbon_on_my_cornflakes

04/16/21 6:01 PM

#159372 RE: justdafactss #159310

Philippines came later: 10Q confirmed NO REVENUES to date--

For the three and nine months ended February 28, 2021 and February 29, 2020,

Doses to Philippines were sent AFTER February 29